nodes	percent_of_prediction	percent_of_DWPC	metapath
Delavirdine—CYP1A2—Anagrelide—hematologic cancer	0.0258	0.0375	CbGbCtD
Delavirdine—CYP2C9—Bexarotene—hematologic cancer	0.0161	0.0234	CbGbCtD
Delavirdine—CYP3A7-CYP3A51P—Ifosfamide—hematologic cancer	0.015	0.0219	CbGbCtD
Delavirdine—CYP3A7—Ifosfamide—hematologic cancer	0.015	0.0219	CbGbCtD
Delavirdine—CYP3A7—Imatinib—hematologic cancer	0.0144	0.0209	CbGbCtD
Delavirdine—CYP3A7-CYP3A51P—Imatinib—hematologic cancer	0.0144	0.0209	CbGbCtD
Delavirdine—CYP2C8—Bortezomib—hematologic cancer	0.0141	0.0206	CbGbCtD
Delavirdine—CYP3A5—Daunorubicin—hematologic cancer	0.0141	0.0205	CbGbCtD
Delavirdine—CYP2D6—Lomustine—hematologic cancer	0.0137	0.0199	CbGbCtD
Delavirdine—CYP1A2—Carmustine—hematologic cancer	0.0135	0.0197	CbGbCtD
Delavirdine—CYP2C9—Idarubicin—hematologic cancer	0.0133	0.0194	CbGbCtD
Delavirdine—CYP3A5—Thalidomide—hematologic cancer	0.0128	0.0186	CbGbCtD
Delavirdine—CYP3A5—Teniposide—hematologic cancer	0.0122	0.0178	CbGbCtD
Delavirdine—CYP2D6—Idarubicin—hematologic cancer	0.0122	0.0177	CbGbCtD
Delavirdine—CYP2C19—Bortezomib—hematologic cancer	0.0119	0.0173	CbGbCtD
Delavirdine—CYP1A2—Methoxsalen—hematologic cancer	0.0115	0.0167	CbGbCtD
Delavirdine—CYP3A5—Ifosfamide—hematologic cancer	0.0113	0.0164	CbGbCtD
Delavirdine—CYP1A2—Bortezomib—hematologic cancer	0.0109	0.0159	CbGbCtD
Delavirdine—CYP2C8—Ifosfamide—hematologic cancer	0.0108	0.0158	CbGbCtD
Delavirdine—CYP3A5—Imatinib—hematologic cancer	0.0108	0.0157	CbGbCtD
Delavirdine—CYP1A2—Daunorubicin—hematologic cancer	0.0105	0.0152	CbGbCtD
Delavirdine—CYP2D6—Hydroxyurea—hematologic cancer	0.0104	0.0151	CbGbCtD
Delavirdine—CYP2C19—Thalidomide—hematologic cancer	0.0103	0.015	CbGbCtD
Delavirdine—CYP1A2—Alitretinoin—hematologic cancer	0.0103	0.0149	CbGbCtD
Delavirdine—CYP2C9—Bortezomib—hematologic cancer	0.00986	0.0143	CbGbCtD
Delavirdine—CYP2C19—Teniposide—hematologic cancer	0.00986	0.0143	CbGbCtD
Delavirdine—CYP1A2—Thalidomide—hematologic cancer	0.00954	0.0139	CbGbCtD
Delavirdine—CYP2C8—Nilotinib—hematologic cancer	0.00941	0.0137	CbGbCtD
Delavirdine—CYP3A4—Bexarotene—hematologic cancer	0.00936	0.0136	CbGbCtD
Delavirdine—CYP2C19—Ifosfamide—hematologic cancer	0.0091	0.0132	CbGbCtD
Delavirdine—CYP2D6—Bortezomib—hematologic cancer	0.00902	0.0131	CbGbCtD
Delavirdine—CYP3A7-CYP3A51P—Irinotecan—hematologic cancer	0.00897	0.013	CbGbCtD
Delavirdine—CYP3A7—Irinotecan—hematologic cancer	0.00897	0.013	CbGbCtD
Delavirdine—CYP3A4—Busulfan—hematologic cancer	0.0087	0.0127	CbGbCtD
Delavirdine—CYP3A4—Lomustine—hematologic cancer	0.0087	0.0127	CbGbCtD
Delavirdine—CYP2C19—Imatinib—hematologic cancer	0.00869	0.0126	CbGbCtD
Delavirdine—CYP3A5—Dasatinib—hematologic cancer	0.00865	0.0126	CbGbCtD
Delavirdine—CYP2C9—Thalidomide—hematologic cancer	0.00859	0.0125	CbGbCtD
Delavirdine—CYP1A2—Dacarbazine—hematologic cancer	0.0082	0.0119	CbGbCtD
Delavirdine—CYP2C9—Teniposide—hematologic cancer	0.0082	0.0119	CbGbCtD
Delavirdine—CYP1A2—Imatinib—hematologic cancer	0.00802	0.0117	CbGbCtD
Delavirdine—CYP3A7—Vincristine—hematologic cancer	0.00784	0.0114	CbGbCtD
Delavirdine—CYP3A7-CYP3A51P—Vincristine—hematologic cancer	0.00784	0.0114	CbGbCtD
Delavirdine—CYP3A4—Thiotepa—hematologic cancer	0.00775	0.0113	CbGbCtD
Delavirdine—CYP2C9—Ifosfamide—hematologic cancer	0.00756	0.011	CbGbCtD
Delavirdine—CYP2C9—Imatinib—hematologic cancer	0.00723	0.0105	CbGbCtD
Delavirdine—CYP3A5—Irinotecan—hematologic cancer	0.00673	0.00979	CbGbCtD
Delavirdine—CYP2D6—Imatinib—hematologic cancer	0.00661	0.00961	CbGbCtD
Delavirdine—CYP2C9—Nilotinib—hematologic cancer	0.00657	0.00955	CbGbCtD
Delavirdine—CYP1A2—Dasatinib—hematologic cancer	0.00644	0.00937	CbGbCtD
Delavirdine—CYP3A4—Methoxsalen—hematologic cancer	0.00603	0.00877	CbGbCtD
Delavirdine—CYP2D6—Nilotinib—hematologic cancer	0.006	0.00873	CbGbCtD
Delavirdine—CYP2D6—Vinorelbine—hematologic cancer	0.00595	0.00866	CbGbCtD
Delavirdine—CYP3A7-CYP3A51P—Dexamethasone—hematologic cancer	0.00591	0.00859	CbGbCtD
Delavirdine—CYP3A7—Dexamethasone—hematologic cancer	0.00591	0.00859	CbGbCtD
Delavirdine—CYP3A5—Vincristine—hematologic cancer	0.00588	0.00856	CbGbCtD
Delavirdine—CYP3A4—Bortezomib—hematologic cancer	0.00573	0.00834	CbGbCtD
Delavirdine—CYP2C19—Prednisone—hematologic cancer	0.00573	0.00833	CbGbCtD
Delavirdine—CYP3A4—Daunorubicin—hematologic cancer	0.00549	0.00798	CbGbCtD
Delavirdine—CYP3A5—Etoposide—hematologic cancer	0.00539	0.00784	CbGbCtD
Delavirdine—CYP2C8—Etoposide—hematologic cancer	0.00518	0.00754	CbGbCtD
Delavirdine—CYP3A4—Cytarabine—hematologic cancer	0.00484	0.00704	CbGbCtD
Delavirdine—CYP3A4—Teniposide—hematologic cancer	0.00477	0.00693	CbGbCtD
Delavirdine—CYP3A5—Dexamethasone—hematologic cancer	0.00443	0.00645	CbGbCtD
Delavirdine—CYP3A4—Ifosfamide—hematologic cancer	0.0044	0.0064	CbGbCtD
Delavirdine—CYP2C8—Dexamethasone—hematologic cancer	0.00426	0.0062	CbGbCtD
Delavirdine—CYP3A4—Imatinib—hematologic cancer	0.0042	0.00611	CbGbCtD
Delavirdine—CYP1A2—Etoposide—hematologic cancer	0.00401	0.00583	CbGbCtD
Delavirdine—CYP3A4—Ruxolitinib—hematologic cancer	0.00396	0.00575	CbGbCtD
Delavirdine—CYP3A4—Nilotinib—hematologic cancer	0.00382	0.00555	CbGbCtD
Delavirdine—CYP3A4—Vinorelbine—hematologic cancer	0.00379	0.00551	CbGbCtD
Delavirdine—CYP2C9—Cisplatin—hematologic cancer	0.00368	0.00535	CbGbCtD
Delavirdine—CYP2D6—Vinblastine—hematologic cancer	0.00367	0.00534	CbGbCtD
Delavirdine—CYP2C19—Dexamethasone—hematologic cancer	0.00357	0.0052	CbGbCtD
Delavirdine—CYP3A4—Triamcinolone—hematologic cancer	0.00346	0.00504	CbGbCtD
Delavirdine—CYP3A4—Dasatinib—hematologic cancer	0.00337	0.00491	CbGbCtD
Delavirdine—CYP3A4—Mitoxantrone—hematologic cancer	0.00333	0.00485	CbGbCtD
Delavirdine—CYP2C9—Dexamethasone—hematologic cancer	0.00297	0.00432	CbGbCtD
Delavirdine—CYP3A4—Betamethasone—hematologic cancer	0.00297	0.00432	CbGbCtD
Delavirdine—CYP3A4—Prednisolone—hematologic cancer	0.00293	0.00426	CbGbCtD
Delavirdine—CYP3A4—Prednisone—hematologic cancer	0.00277	0.00403	CbGbCtD
Delavirdine—CYP2D6—Dexamethasone—hematologic cancer	0.00272	0.00395	CbGbCtD
Delavirdine—CYP3A4—Irinotecan—hematologic cancer	0.00262	0.00382	CbGbCtD
Delavirdine—CYP3A4—Vinblastine—hematologic cancer	0.00233	0.00339	CbGbCtD
Delavirdine—CYP3A4—Vincristine—hematologic cancer	0.00229	0.00334	CbGbCtD
Delavirdine—CYP2D6—Doxorubicin—hematologic cancer	0.00225	0.00328	CbGbCtD
Delavirdine—CYP3A4—Etoposide—hematologic cancer	0.0021	0.00306	CbGbCtD
Delavirdine—CYP3A4—Dexamethasone—hematologic cancer	0.00173	0.00251	CbGbCtD
Delavirdine—CYP3A4—Doxorubicin—hematologic cancer	0.00143	0.00209	CbGbCtD
Delavirdine—Skin disorder—Prednisone—hematologic cancer	1.8e-05	6.11e-05	CcSEcCtD
Delavirdine—Nausea—Gemcitabine—hematologic cancer	1.8e-05	6.1e-05	CcSEcCtD
Delavirdine—Vomiting—Cisplatin—hematologic cancer	1.8e-05	6.09e-05	CcSEcCtD
Delavirdine—Hyperhidrosis—Prednisone—hematologic cancer	1.79e-05	6.08e-05	CcSEcCtD
Delavirdine—Vision blurred—Methotrexate—hematologic cancer	1.79e-05	6.07e-05	CcSEcCtD
Delavirdine—Erythema multiforme—Doxorubicin—hematologic cancer	1.79e-05	6.05e-05	CcSEcCtD
Delavirdine—Rash—Cisplatin—hematologic cancer	1.78e-05	6.04e-05	CcSEcCtD
Delavirdine—Dermatitis—Cisplatin—hematologic cancer	1.78e-05	6.03e-05	CcSEcCtD
Delavirdine—Erythema—Epirubicin—hematologic cancer	1.78e-05	6.02e-05	CcSEcCtD
Delavirdine—Malnutrition—Epirubicin—hematologic cancer	1.78e-05	6.02e-05	CcSEcCtD
Delavirdine—Diarrhoea—Etoposide—hematologic cancer	1.77e-05	6e-05	CcSEcCtD
Delavirdine—Anorexia—Prednisone—hematologic cancer	1.77e-05	5.99e-05	CcSEcCtD
Delavirdine—Ill-defined disorder—Methotrexate—hematologic cancer	1.76e-05	5.97e-05	CcSEcCtD
Delavirdine—Tinnitus—Doxorubicin—hematologic cancer	1.76e-05	5.97e-05	CcSEcCtD
Delavirdine—Anaemia—Methotrexate—hematologic cancer	1.76e-05	5.95e-05	CcSEcCtD
Delavirdine—Feeling abnormal—Dexamethasone—hematologic cancer	1.76e-05	5.95e-05	CcSEcCtD
Delavirdine—Feeling abnormal—Betamethasone—hematologic cancer	1.76e-05	5.95e-05	CcSEcCtD
Delavirdine—Flatulence—Epirubicin—hematologic cancer	1.75e-05	5.94e-05	CcSEcCtD
Delavirdine—Tension—Epirubicin—hematologic cancer	1.75e-05	5.91e-05	CcSEcCtD
Delavirdine—Gastrointestinal pain—Betamethasone—hematologic cancer	1.74e-05	5.9e-05	CcSEcCtD
Delavirdine—Gastrointestinal pain—Dexamethasone—hematologic cancer	1.74e-05	5.9e-05	CcSEcCtD
Delavirdine—Dysgeusia—Epirubicin—hematologic cancer	1.74e-05	5.9e-05	CcSEcCtD
Delavirdine—Hypersensitivity—Triamcinolone—hematologic cancer	1.73e-05	5.86e-05	CcSEcCtD
Delavirdine—Nervousness—Epirubicin—hematologic cancer	1.73e-05	5.85e-05	CcSEcCtD
Delavirdine—Back pain—Epirubicin—hematologic cancer	1.72e-05	5.83e-05	CcSEcCtD
Delavirdine—Malaise—Methotrexate—hematologic cancer	1.71e-05	5.81e-05	CcSEcCtD
Delavirdine—Dizziness—Etoposide—hematologic cancer	1.71e-05	5.8e-05	CcSEcCtD
Delavirdine—Muscle spasms—Epirubicin—hematologic cancer	1.71e-05	5.79e-05	CcSEcCtD
Delavirdine—Vertigo—Methotrexate—hematologic cancer	1.71e-05	5.78e-05	CcSEcCtD
Delavirdine—Leukopenia—Methotrexate—hematologic cancer	1.7e-05	5.76e-05	CcSEcCtD
Delavirdine—Chills—Doxorubicin—hematologic cancer	1.7e-05	5.75e-05	CcSEcCtD
Delavirdine—Urticaria—Betamethasone—hematologic cancer	1.69e-05	5.73e-05	CcSEcCtD
Delavirdine—Urticaria—Dexamethasone—hematologic cancer	1.69e-05	5.73e-05	CcSEcCtD
Delavirdine—Musculoskeletal discomfort—Prednisone—hematologic cancer	1.69e-05	5.73e-05	CcSEcCtD
Delavirdine—Dizziness—Prednisolone—hematologic cancer	1.69e-05	5.72e-05	CcSEcCtD
Delavirdine—Asthenia—Triamcinolone—hematologic cancer	1.69e-05	5.71e-05	CcSEcCtD
Delavirdine—Body temperature increased—Betamethasone—hematologic cancer	1.69e-05	5.71e-05	CcSEcCtD
Delavirdine—Body temperature increased—Dexamethasone—hematologic cancer	1.69e-05	5.71e-05	CcSEcCtD
Delavirdine—Abdominal pain—Betamethasone—hematologic cancer	1.69e-05	5.71e-05	CcSEcCtD
Delavirdine—Abdominal pain—Dexamethasone—hematologic cancer	1.69e-05	5.71e-05	CcSEcCtD
Delavirdine—Nausea—Cisplatin—hematologic cancer	1.68e-05	5.69e-05	CcSEcCtD
Delavirdine—Insomnia—Prednisone—hematologic cancer	1.68e-05	5.69e-05	CcSEcCtD
Delavirdine—Vision blurred—Epirubicin—hematologic cancer	1.68e-05	5.68e-05	CcSEcCtD
Delavirdine—Alopecia—Doxorubicin—hematologic cancer	1.67e-05	5.66e-05	CcSEcCtD
Delavirdine—Paraesthesia—Prednisone—hematologic cancer	1.67e-05	5.65e-05	CcSEcCtD
Delavirdine—Pruritus—Triamcinolone—hematologic cancer	1.66e-05	5.63e-05	CcSEcCtD
Delavirdine—Cough—Methotrexate—hematologic cancer	1.66e-05	5.62e-05	CcSEcCtD
Delavirdine—Ill-defined disorder—Epirubicin—hematologic cancer	1.65e-05	5.59e-05	CcSEcCtD
Delavirdine—Vomiting—Etoposide—hematologic cancer	1.65e-05	5.58e-05	CcSEcCtD
Delavirdine—Erythema—Doxorubicin—hematologic cancer	1.65e-05	5.57e-05	CcSEcCtD
Delavirdine—Malnutrition—Doxorubicin—hematologic cancer	1.65e-05	5.57e-05	CcSEcCtD
Delavirdine—Anaemia—Epirubicin—hematologic cancer	1.64e-05	5.57e-05	CcSEcCtD
Delavirdine—Agitation—Epirubicin—hematologic cancer	1.63e-05	5.54e-05	CcSEcCtD
Delavirdine—Dyspepsia—Prednisone—hematologic cancer	1.63e-05	5.53e-05	CcSEcCtD
Delavirdine—Rash—Etoposide—hematologic cancer	1.63e-05	5.53e-05	CcSEcCtD
Delavirdine—Dermatitis—Etoposide—hematologic cancer	1.63e-05	5.53e-05	CcSEcCtD
Delavirdine—Headache—Etoposide—hematologic cancer	1.62e-05	5.5e-05	CcSEcCtD
Delavirdine—Flatulence—Doxorubicin—hematologic cancer	1.62e-05	5.49e-05	CcSEcCtD
Delavirdine—Myalgia—Methotrexate—hematologic cancer	1.62e-05	5.48e-05	CcSEcCtD
Delavirdine—Arthralgia—Methotrexate—hematologic cancer	1.62e-05	5.48e-05	CcSEcCtD
Delavirdine—Chest pain—Methotrexate—hematologic cancer	1.62e-05	5.48e-05	CcSEcCtD
Delavirdine—Tension—Doxorubicin—hematologic cancer	1.62e-05	5.47e-05	CcSEcCtD
Delavirdine—Decreased appetite—Prednisone—hematologic cancer	1.61e-05	5.47e-05	CcSEcCtD
Delavirdine—Dysgeusia—Doxorubicin—hematologic cancer	1.61e-05	5.46e-05	CcSEcCtD
Delavirdine—Rash—Prednisolone—hematologic cancer	1.61e-05	5.45e-05	CcSEcCtD
Delavirdine—Dermatitis—Prednisolone—hematologic cancer	1.61e-05	5.45e-05	CcSEcCtD
Delavirdine—Malaise—Epirubicin—hematologic cancer	1.6e-05	5.43e-05	CcSEcCtD
Delavirdine—Fatigue—Prednisone—hematologic cancer	1.6e-05	5.42e-05	CcSEcCtD
Delavirdine—Headache—Prednisolone—hematologic cancer	1.6e-05	5.42e-05	CcSEcCtD
Delavirdine—Discomfort—Methotrexate—hematologic cancer	1.6e-05	5.42e-05	CcSEcCtD
Delavirdine—Nervousness—Doxorubicin—hematologic cancer	1.6e-05	5.41e-05	CcSEcCtD
Delavirdine—Vertigo—Epirubicin—hematologic cancer	1.6e-05	5.41e-05	CcSEcCtD
Delavirdine—Syncope—Epirubicin—hematologic cancer	1.6e-05	5.4e-05	CcSEcCtD
Delavirdine—Leukopenia—Epirubicin—hematologic cancer	1.59e-05	5.39e-05	CcSEcCtD
Delavirdine—Back pain—Doxorubicin—hematologic cancer	1.59e-05	5.39e-05	CcSEcCtD
Delavirdine—Constipation—Prednisone—hematologic cancer	1.59e-05	5.38e-05	CcSEcCtD
Delavirdine—Muscle spasms—Doxorubicin—hematologic cancer	1.58e-05	5.36e-05	CcSEcCtD
Delavirdine—Palpitations—Epirubicin—hematologic cancer	1.57e-05	5.32e-05	CcSEcCtD
Delavirdine—Confusional state—Methotrexate—hematologic cancer	1.56e-05	5.3e-05	CcSEcCtD
Delavirdine—Loss of consciousness—Epirubicin—hematologic cancer	1.56e-05	5.3e-05	CcSEcCtD
Delavirdine—Dizziness—Triamcinolone—hematologic cancer	1.55e-05	5.26e-05	CcSEcCtD
Delavirdine—Cough—Epirubicin—hematologic cancer	1.55e-05	5.26e-05	CcSEcCtD
Delavirdine—Vision blurred—Doxorubicin—hematologic cancer	1.55e-05	5.25e-05	CcSEcCtD
Delavirdine—Infection—Methotrexate—hematologic cancer	1.54e-05	5.22e-05	CcSEcCtD
Delavirdine—Nausea—Etoposide—hematologic cancer	1.54e-05	5.21e-05	CcSEcCtD
Delavirdine—Hypertension—Epirubicin—hematologic cancer	1.54e-05	5.2e-05	CcSEcCtD
Delavirdine—Feeling abnormal—Prednisone—hematologic cancer	1.53e-05	5.18e-05	CcSEcCtD
Delavirdine—Asthenia—Betamethasone—hematologic cancer	1.53e-05	5.18e-05	CcSEcCtD
Delavirdine—Asthenia—Dexamethasone—hematologic cancer	1.53e-05	5.18e-05	CcSEcCtD
Delavirdine—Ill-defined disorder—Doxorubicin—hematologic cancer	1.53e-05	5.17e-05	CcSEcCtD
Delavirdine—Anaemia—Doxorubicin—hematologic cancer	1.52e-05	5.15e-05	CcSEcCtD
Delavirdine—Thrombocytopenia—Methotrexate—hematologic cancer	1.52e-05	5.14e-05	CcSEcCtD
Delavirdine—Gastrointestinal pain—Prednisone—hematologic cancer	1.52e-05	5.14e-05	CcSEcCtD
Delavirdine—Nausea—Prednisolone—hematologic cancer	1.52e-05	5.14e-05	CcSEcCtD
Delavirdine—Chest pain—Epirubicin—hematologic cancer	1.51e-05	5.13e-05	CcSEcCtD
Delavirdine—Myalgia—Epirubicin—hematologic cancer	1.51e-05	5.13e-05	CcSEcCtD
Delavirdine—Arthralgia—Epirubicin—hematologic cancer	1.51e-05	5.13e-05	CcSEcCtD
Delavirdine—Agitation—Doxorubicin—hematologic cancer	1.51e-05	5.12e-05	CcSEcCtD
Delavirdine—Anxiety—Epirubicin—hematologic cancer	1.51e-05	5.11e-05	CcSEcCtD
Delavirdine—Pruritus—Dexamethasone—hematologic cancer	1.51e-05	5.11e-05	CcSEcCtD
Delavirdine—Pruritus—Betamethasone—hematologic cancer	1.51e-05	5.11e-05	CcSEcCtD
Delavirdine—Skin disorder—Methotrexate—hematologic cancer	1.51e-05	5.1e-05	CcSEcCtD
Delavirdine—Hyperhidrosis—Methotrexate—hematologic cancer	1.5e-05	5.08e-05	CcSEcCtD
Delavirdine—Discomfort—Epirubicin—hematologic cancer	1.5e-05	5.07e-05	CcSEcCtD
Delavirdine—Vomiting—Triamcinolone—hematologic cancer	1.49e-05	5.06e-05	CcSEcCtD
Delavirdine—Malaise—Doxorubicin—hematologic cancer	1.48e-05	5.03e-05	CcSEcCtD
Delavirdine—Rash—Triamcinolone—hematologic cancer	1.48e-05	5.02e-05	CcSEcCtD
Delavirdine—Dry mouth—Epirubicin—hematologic cancer	1.48e-05	5.02e-05	CcSEcCtD
Delavirdine—Dermatitis—Triamcinolone—hematologic cancer	1.48e-05	5.01e-05	CcSEcCtD
Delavirdine—Vertigo—Doxorubicin—hematologic cancer	1.48e-05	5.01e-05	CcSEcCtD
Delavirdine—Anorexia—Methotrexate—hematologic cancer	1.48e-05	5.01e-05	CcSEcCtD
Delavirdine—Syncope—Doxorubicin—hematologic cancer	1.48e-05	5e-05	CcSEcCtD
Delavirdine—Urticaria—Prednisone—hematologic cancer	1.47e-05	4.99e-05	CcSEcCtD
Delavirdine—Leukopenia—Doxorubicin—hematologic cancer	1.47e-05	4.99e-05	CcSEcCtD
Delavirdine—Headache—Triamcinolone—hematologic cancer	1.47e-05	4.98e-05	CcSEcCtD
Delavirdine—Abdominal pain—Prednisone—hematologic cancer	1.47e-05	4.97e-05	CcSEcCtD
Delavirdine—Body temperature increased—Prednisone—hematologic cancer	1.47e-05	4.97e-05	CcSEcCtD
Delavirdine—Confusional state—Epirubicin—hematologic cancer	1.46e-05	4.96e-05	CcSEcCtD
Delavirdine—Diarrhoea—Dexamethasone—hematologic cancer	1.46e-05	4.94e-05	CcSEcCtD
Delavirdine—Diarrhoea—Betamethasone—hematologic cancer	1.46e-05	4.94e-05	CcSEcCtD
Delavirdine—Palpitations—Doxorubicin—hematologic cancer	1.45e-05	4.93e-05	CcSEcCtD
Delavirdine—Oedema—Epirubicin—hematologic cancer	1.45e-05	4.92e-05	CcSEcCtD
Delavirdine—Hypotension—Methotrexate—hematologic cancer	1.45e-05	4.91e-05	CcSEcCtD
Delavirdine—Loss of consciousness—Doxorubicin—hematologic cancer	1.45e-05	4.9e-05	CcSEcCtD
Delavirdine—Infection—Epirubicin—hematologic cancer	1.44e-05	4.88e-05	CcSEcCtD
Delavirdine—Cough—Doxorubicin—hematologic cancer	1.44e-05	4.86e-05	CcSEcCtD
Delavirdine—Shock—Epirubicin—hematologic cancer	1.43e-05	4.84e-05	CcSEcCtD
Delavirdine—Thrombocytopenia—Epirubicin—hematologic cancer	1.42e-05	4.81e-05	CcSEcCtD
Delavirdine—Hypertension—Doxorubicin—hematologic cancer	1.42e-05	4.81e-05	CcSEcCtD
Delavirdine—Tachycardia—Epirubicin—hematologic cancer	1.42e-05	4.8e-05	CcSEcCtD
Delavirdine—Musculoskeletal discomfort—Methotrexate—hematologic cancer	1.41e-05	4.79e-05	CcSEcCtD
Delavirdine—Skin disorder—Epirubicin—hematologic cancer	1.41e-05	4.78e-05	CcSEcCtD
Delavirdine—Dizziness—Dexamethasone—hematologic cancer	1.41e-05	4.77e-05	CcSEcCtD
Delavirdine—Dizziness—Betamethasone—hematologic cancer	1.41e-05	4.77e-05	CcSEcCtD
Delavirdine—Hyperhidrosis—Epirubicin—hematologic cancer	1.4e-05	4.75e-05	CcSEcCtD
Delavirdine—Insomnia—Methotrexate—hematologic cancer	1.4e-05	4.75e-05	CcSEcCtD
Delavirdine—Chest pain—Doxorubicin—hematologic cancer	1.4e-05	4.75e-05	CcSEcCtD
Delavirdine—Myalgia—Doxorubicin—hematologic cancer	1.4e-05	4.75e-05	CcSEcCtD
Delavirdine—Arthralgia—Doxorubicin—hematologic cancer	1.4e-05	4.75e-05	CcSEcCtD
Delavirdine—Anxiety—Doxorubicin—hematologic cancer	1.4e-05	4.73e-05	CcSEcCtD
Delavirdine—Nausea—Triamcinolone—hematologic cancer	1.4e-05	4.73e-05	CcSEcCtD
Delavirdine—Paraesthesia—Methotrexate—hematologic cancer	1.39e-05	4.72e-05	CcSEcCtD
Delavirdine—Discomfort—Doxorubicin—hematologic cancer	1.38e-05	4.69e-05	CcSEcCtD
Delavirdine—Anorexia—Epirubicin—hematologic cancer	1.38e-05	4.69e-05	CcSEcCtD
Delavirdine—Dyspnoea—Methotrexate—hematologic cancer	1.38e-05	4.68e-05	CcSEcCtD
Delavirdine—Somnolence—Methotrexate—hematologic cancer	1.38e-05	4.67e-05	CcSEcCtD
Delavirdine—Dry mouth—Doxorubicin—hematologic cancer	1.37e-05	4.64e-05	CcSEcCtD
Delavirdine—Hypersensitivity—Prednisone—hematologic cancer	1.37e-05	4.63e-05	CcSEcCtD
Delavirdine—Dyspepsia—Methotrexate—hematologic cancer	1.37e-05	4.62e-05	CcSEcCtD
Delavirdine—Hypotension—Epirubicin—hematologic cancer	1.36e-05	4.59e-05	CcSEcCtD
Delavirdine—Vomiting—Dexamethasone—hematologic cancer	1.36e-05	4.59e-05	CcSEcCtD
Delavirdine—Vomiting—Betamethasone—hematologic cancer	1.36e-05	4.59e-05	CcSEcCtD
Delavirdine—Confusional state—Doxorubicin—hematologic cancer	1.35e-05	4.59e-05	CcSEcCtD
Delavirdine—Decreased appetite—Methotrexate—hematologic cancer	1.35e-05	4.57e-05	CcSEcCtD
Delavirdine—Rash—Betamethasone—hematologic cancer	1.34e-05	4.55e-05	CcSEcCtD
Delavirdine—Rash—Dexamethasone—hematologic cancer	1.34e-05	4.55e-05	CcSEcCtD
Delavirdine—Oedema—Doxorubicin—hematologic cancer	1.34e-05	4.55e-05	CcSEcCtD
Delavirdine—Dermatitis—Dexamethasone—hematologic cancer	1.34e-05	4.55e-05	CcSEcCtD
Delavirdine—Dermatitis—Betamethasone—hematologic cancer	1.34e-05	4.55e-05	CcSEcCtD
Delavirdine—Gastrointestinal disorder—Methotrexate—hematologic cancer	1.34e-05	4.54e-05	CcSEcCtD
Delavirdine—Fatigue—Methotrexate—hematologic cancer	1.34e-05	4.53e-05	CcSEcCtD
Delavirdine—Headache—Betamethasone—hematologic cancer	1.34e-05	4.52e-05	CcSEcCtD
Delavirdine—Headache—Dexamethasone—hematologic cancer	1.34e-05	4.52e-05	CcSEcCtD
Delavirdine—Infection—Doxorubicin—hematologic cancer	1.33e-05	4.52e-05	CcSEcCtD
Delavirdine—Asthenia—Prednisone—hematologic cancer	1.33e-05	4.51e-05	CcSEcCtD
Delavirdine—Pain—Methotrexate—hematologic cancer	1.33e-05	4.49e-05	CcSEcCtD
Delavirdine—Musculoskeletal discomfort—Epirubicin—hematologic cancer	1.32e-05	4.48e-05	CcSEcCtD
Delavirdine—Shock—Doxorubicin—hematologic cancer	1.32e-05	4.48e-05	CcSEcCtD
Delavirdine—Thrombocytopenia—Doxorubicin—hematologic cancer	1.32e-05	4.45e-05	CcSEcCtD
Delavirdine—Pruritus—Prednisone—hematologic cancer	1.31e-05	4.45e-05	CcSEcCtD
Delavirdine—Insomnia—Epirubicin—hematologic cancer	1.31e-05	4.45e-05	CcSEcCtD
Delavirdine—Tachycardia—Doxorubicin—hematologic cancer	1.31e-05	4.44e-05	CcSEcCtD
Delavirdine—Skin disorder—Doxorubicin—hematologic cancer	1.3e-05	4.42e-05	CcSEcCtD
Delavirdine—Paraesthesia—Epirubicin—hematologic cancer	1.3e-05	4.42e-05	CcSEcCtD
Delavirdine—Hyperhidrosis—Doxorubicin—hematologic cancer	1.3e-05	4.4e-05	CcSEcCtD
Delavirdine—Dyspnoea—Epirubicin—hematologic cancer	1.29e-05	4.38e-05	CcSEcCtD
Delavirdine—Somnolence—Epirubicin—hematologic cancer	1.29e-05	4.37e-05	CcSEcCtD
Delavirdine—Anorexia—Doxorubicin—hematologic cancer	1.28e-05	4.34e-05	CcSEcCtD
Delavirdine—Feeling abnormal—Methotrexate—hematologic cancer	1.28e-05	4.33e-05	CcSEcCtD
Delavirdine—Dyspepsia—Epirubicin—hematologic cancer	1.28e-05	4.33e-05	CcSEcCtD
Delavirdine—Diarrhoea—Prednisone—hematologic cancer	1.27e-05	4.3e-05	CcSEcCtD
Delavirdine—Gastrointestinal pain—Methotrexate—hematologic cancer	1.27e-05	4.3e-05	CcSEcCtD
Delavirdine—Nausea—Betamethasone—hematologic cancer	1.27e-05	4.29e-05	CcSEcCtD
Delavirdine—Nausea—Dexamethasone—hematologic cancer	1.27e-05	4.29e-05	CcSEcCtD
Delavirdine—Decreased appetite—Epirubicin—hematologic cancer	1.26e-05	4.27e-05	CcSEcCtD
Delavirdine—Hypotension—Doxorubicin—hematologic cancer	1.26e-05	4.25e-05	CcSEcCtD
Delavirdine—Gastrointestinal disorder—Epirubicin—hematologic cancer	1.25e-05	4.24e-05	CcSEcCtD
Delavirdine—Fatigue—Epirubicin—hematologic cancer	1.25e-05	4.24e-05	CcSEcCtD
Delavirdine—Pain—Epirubicin—hematologic cancer	1.24e-05	4.2e-05	CcSEcCtD
Delavirdine—Constipation—Epirubicin—hematologic cancer	1.24e-05	4.2e-05	CcSEcCtD
Delavirdine—Urticaria—Methotrexate—hematologic cancer	1.23e-05	4.17e-05	CcSEcCtD
Delavirdine—Dizziness—Prednisone—hematologic cancer	1.23e-05	4.16e-05	CcSEcCtD
Delavirdine—Abdominal pain—Methotrexate—hematologic cancer	1.23e-05	4.15e-05	CcSEcCtD
Delavirdine—Body temperature increased—Methotrexate—hematologic cancer	1.23e-05	4.15e-05	CcSEcCtD
Delavirdine—Musculoskeletal discomfort—Doxorubicin—hematologic cancer	1.22e-05	4.14e-05	CcSEcCtD
Delavirdine—Insomnia—Doxorubicin—hematologic cancer	1.22e-05	4.11e-05	CcSEcCtD
Delavirdine—Paraesthesia—Doxorubicin—hematologic cancer	1.21e-05	4.09e-05	CcSEcCtD
Delavirdine—Dyspnoea—Doxorubicin—hematologic cancer	1.2e-05	4.06e-05	CcSEcCtD
Delavirdine—Feeling abnormal—Epirubicin—hematologic cancer	1.2e-05	4.05e-05	CcSEcCtD
Delavirdine—Somnolence—Doxorubicin—hematologic cancer	1.19e-05	4.04e-05	CcSEcCtD
Delavirdine—Gastrointestinal pain—Epirubicin—hematologic cancer	1.19e-05	4.02e-05	CcSEcCtD
Delavirdine—Dyspepsia—Doxorubicin—hematologic cancer	1.18e-05	4e-05	CcSEcCtD
Delavirdine—Vomiting—Prednisone—hematologic cancer	1.18e-05	4e-05	CcSEcCtD
Delavirdine—Rash—Prednisone—hematologic cancer	1.17e-05	3.96e-05	CcSEcCtD
Delavirdine—Dermatitis—Prednisone—hematologic cancer	1.17e-05	3.96e-05	CcSEcCtD
Delavirdine—Decreased appetite—Doxorubicin—hematologic cancer	1.17e-05	3.95e-05	CcSEcCtD
Delavirdine—Headache—Prednisone—hematologic cancer	1.16e-05	3.94e-05	CcSEcCtD
Delavirdine—Gastrointestinal disorder—Doxorubicin—hematologic cancer	1.16e-05	3.93e-05	CcSEcCtD
Delavirdine—Fatigue—Doxorubicin—hematologic cancer	1.16e-05	3.92e-05	CcSEcCtD
Delavirdine—Urticaria—Epirubicin—hematologic cancer	1.15e-05	3.91e-05	CcSEcCtD
Delavirdine—Constipation—Doxorubicin—hematologic cancer	1.15e-05	3.89e-05	CcSEcCtD
Delavirdine—Pain—Doxorubicin—hematologic cancer	1.15e-05	3.89e-05	CcSEcCtD
Delavirdine—Body temperature increased—Epirubicin—hematologic cancer	1.15e-05	3.89e-05	CcSEcCtD
Delavirdine—Abdominal pain—Epirubicin—hematologic cancer	1.15e-05	3.89e-05	CcSEcCtD
Delavirdine—Hypersensitivity—Methotrexate—hematologic cancer	1.14e-05	3.87e-05	CcSEcCtD
Delavirdine—Asthenia—Methotrexate—hematologic cancer	1.11e-05	3.77e-05	CcSEcCtD
Delavirdine—Feeling abnormal—Doxorubicin—hematologic cancer	1.11e-05	3.75e-05	CcSEcCtD
Delavirdine—Nausea—Prednisone—hematologic cancer	1.1e-05	3.73e-05	CcSEcCtD
Delavirdine—Gastrointestinal pain—Doxorubicin—hematologic cancer	1.1e-05	3.72e-05	CcSEcCtD
Delavirdine—Pruritus—Methotrexate—hematologic cancer	1.1e-05	3.72e-05	CcSEcCtD
Delavirdine—Hypersensitivity—Epirubicin—hematologic cancer	1.07e-05	3.62e-05	CcSEcCtD
Delavirdine—Urticaria—Doxorubicin—hematologic cancer	1.07e-05	3.61e-05	CcSEcCtD
Delavirdine—Body temperature increased—Doxorubicin—hematologic cancer	1.06e-05	3.6e-05	CcSEcCtD
Delavirdine—Abdominal pain—Doxorubicin—hematologic cancer	1.06e-05	3.6e-05	CcSEcCtD
Delavirdine—Diarrhoea—Methotrexate—hematologic cancer	1.06e-05	3.59e-05	CcSEcCtD
Delavirdine—Asthenia—Epirubicin—hematologic cancer	1.04e-05	3.53e-05	CcSEcCtD
Delavirdine—Pruritus—Epirubicin—hematologic cancer	1.03e-05	3.48e-05	CcSEcCtD
Delavirdine—Dizziness—Methotrexate—hematologic cancer	1.03e-05	3.47e-05	CcSEcCtD
Delavirdine—Diarrhoea—Epirubicin—hematologic cancer	9.93e-06	3.36e-05	CcSEcCtD
Delavirdine—Hypersensitivity—Doxorubicin—hematologic cancer	9.9e-06	3.35e-05	CcSEcCtD
Delavirdine—Vomiting—Methotrexate—hematologic cancer	9.87e-06	3.34e-05	CcSEcCtD
Delavirdine—Rash—Methotrexate—hematologic cancer	9.78e-06	3.31e-05	CcSEcCtD
Delavirdine—Dermatitis—Methotrexate—hematologic cancer	9.77e-06	3.31e-05	CcSEcCtD
Delavirdine—Headache—Methotrexate—hematologic cancer	9.72e-06	3.29e-05	CcSEcCtD
Delavirdine—Asthenia—Doxorubicin—hematologic cancer	9.64e-06	3.26e-05	CcSEcCtD
Delavirdine—Dizziness—Epirubicin—hematologic cancer	9.6e-06	3.25e-05	CcSEcCtD
Delavirdine—Pruritus—Doxorubicin—hematologic cancer	9.51e-06	3.22e-05	CcSEcCtD
Delavirdine—Vomiting—Epirubicin—hematologic cancer	9.23e-06	3.13e-05	CcSEcCtD
Delavirdine—Nausea—Methotrexate—hematologic cancer	9.22e-06	3.12e-05	CcSEcCtD
Delavirdine—Diarrhoea—Doxorubicin—hematologic cancer	9.19e-06	3.11e-05	CcSEcCtD
Delavirdine—Rash—Epirubicin—hematologic cancer	9.16e-06	3.1e-05	CcSEcCtD
Delavirdine—Dermatitis—Epirubicin—hematologic cancer	9.15e-06	3.1e-05	CcSEcCtD
Delavirdine—Headache—Epirubicin—hematologic cancer	9.1e-06	3.08e-05	CcSEcCtD
Delavirdine—Dizziness—Doxorubicin—hematologic cancer	8.88e-06	3.01e-05	CcSEcCtD
Delavirdine—Nausea—Epirubicin—hematologic cancer	8.62e-06	2.92e-05	CcSEcCtD
Delavirdine—Vomiting—Doxorubicin—hematologic cancer	8.54e-06	2.89e-05	CcSEcCtD
Delavirdine—Rash—Doxorubicin—hematologic cancer	8.47e-06	2.87e-05	CcSEcCtD
Delavirdine—Dermatitis—Doxorubicin—hematologic cancer	8.46e-06	2.87e-05	CcSEcCtD
Delavirdine—Headache—Doxorubicin—hematologic cancer	8.42e-06	2.85e-05	CcSEcCtD
Delavirdine—Nausea—Doxorubicin—hematologic cancer	7.98e-06	2.7e-05	CcSEcCtD
Delavirdine—CYP2C9—Metabolism—CRABP1—hematologic cancer	3.78e-06	0.000221	CbGpPWpGaD
Delavirdine—CYP3A5—Metabolism—CD44—hematologic cancer	3.77e-06	0.000221	CbGpPWpGaD
Delavirdine—CYP3A5—Metabolism—NQO1—hematologic cancer	3.77e-06	0.000221	CbGpPWpGaD
Delavirdine—CYP2C19—Metabolism—NUP214—hematologic cancer	3.77e-06	0.00022	CbGpPWpGaD
Delavirdine—CYP1A2—Metabolism—NCOR2—hematologic cancer	3.74e-06	0.000219	CbGpPWpGaD
Delavirdine—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CG—hematologic cancer	3.73e-06	0.000218	CbGpPWpGaD
Delavirdine—CYP2D6—Metabolism—ALOX5—hematologic cancer	3.71e-06	0.000217	CbGpPWpGaD
Delavirdine—CYP2C19—Metabolism—MTR—hematologic cancer	3.69e-06	0.000216	CbGpPWpGaD
Delavirdine—CYP2C19—Metabolism—ABCG2—hematologic cancer	3.69e-06	0.000216	CbGpPWpGaD
Delavirdine—CYP2C9—Metabolism—ALOX5—hematologic cancer	3.68e-06	0.000215	CbGpPWpGaD
Delavirdine—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CD—hematologic cancer	3.67e-06	0.000215	CbGpPWpGaD
Delavirdine—CYP2C8—Metabolism of lipids and lipoproteins—ALB—hematologic cancer	3.62e-06	0.000212	CbGpPWpGaD
Delavirdine—CYP2C19—Metabolism—ENO2—hematologic cancer	3.62e-06	0.000212	CbGpPWpGaD
Delavirdine—CYP2D6—Metabolism—NUP98—hematologic cancer	3.59e-06	0.00021	CbGpPWpGaD
Delavirdine—CYP3A5—Metabolism—CYCS—hematologic cancer	3.57e-06	0.000209	CbGpPWpGaD
Delavirdine—CYP1A2—Metabolism—IDH1—hematologic cancer	3.57e-06	0.000209	CbGpPWpGaD
Delavirdine—CYP2C9—Metabolism—NUP98—hematologic cancer	3.56e-06	0.000209	CbGpPWpGaD
Delavirdine—CYP3A5—Metabolism—HSP90AA1—hematologic cancer	3.55e-06	0.000208	CbGpPWpGaD
Delavirdine—CYP3A7—Metabolism—MTHFR—hematologic cancer	3.54e-06	0.000207	CbGpPWpGaD
Delavirdine—CYP1A2—Metabolism—ABCC3—hematologic cancer	3.53e-06	0.000206	CbGpPWpGaD
Delavirdine—CYP1A2—Metabolism—GSTO1—hematologic cancer	3.53e-06	0.000206	CbGpPWpGaD
Delavirdine—CYP1A2—Metabolism—TXN—hematologic cancer	3.53e-06	0.000206	CbGpPWpGaD
Delavirdine—CYP2C19—Metabolism—GSTT1—hematologic cancer	3.51e-06	0.000205	CbGpPWpGaD
Delavirdine—CYP2D6—Metabolism—ADCY7—hematologic cancer	3.49e-06	0.000204	CbGpPWpGaD
Delavirdine—CYP2D6—Metabolism—NCOA3—hematologic cancer	3.49e-06	0.000204	CbGpPWpGaD
Delavirdine—CYP2C8—Metabolism of lipids and lipoproteins—PIK3R1—hematologic cancer	3.47e-06	0.000203	CbGpPWpGaD
Delavirdine—CYP2D6—Metabolism—NUP214—hematologic cancer	3.46e-06	0.000203	CbGpPWpGaD
Delavirdine—CYP2C9—Metabolism—NCOA3—hematologic cancer	3.46e-06	0.000202	CbGpPWpGaD
Delavirdine—CYP2C9—Metabolism—ADCY7—hematologic cancer	3.46e-06	0.000202	CbGpPWpGaD
Delavirdine—CYP2C19—Metabolism of lipids and lipoproteins—CREBBP—hematologic cancer	3.46e-06	0.000202	CbGpPWpGaD
Delavirdine—CYP1A2—Metabolism—SPHK1—hematologic cancer	3.45e-06	0.000202	CbGpPWpGaD
Delavirdine—CYP3A4—Metabolism—FHL2—hematologic cancer	3.44e-06	0.000202	CbGpPWpGaD
Delavirdine—CYP2C9—Metabolism—NUP214—hematologic cancer	3.43e-06	0.000201	CbGpPWpGaD
Delavirdine—CYP2C19—Metabolism—SDC1—hematologic cancer	3.43e-06	0.000201	CbGpPWpGaD
Delavirdine—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CG—hematologic cancer	3.4e-06	0.000199	CbGpPWpGaD
Delavirdine—CYP2D6—Metabolism—ABCG2—hematologic cancer	3.39e-06	0.000199	CbGpPWpGaD
Delavirdine—CYP2D6—Metabolism—MTR—hematologic cancer	3.39e-06	0.000199	CbGpPWpGaD
Delavirdine—CYP3A4—Metabolism—AGRN—hematologic cancer	3.38e-06	0.000198	CbGpPWpGaD
Delavirdine—CYP2C9—Metabolism—MTR—hematologic cancer	3.36e-06	0.000197	CbGpPWpGaD
Delavirdine—CYP2C9—Metabolism—ABCG2—hematologic cancer	3.36e-06	0.000197	CbGpPWpGaD
Delavirdine—CYP2D6—Metabolism—ENO2—hematologic cancer	3.33e-06	0.000195	CbGpPWpGaD
Delavirdine—CYP1A2—Metabolism—UGT1A1—hematologic cancer	3.32e-06	0.000194	CbGpPWpGaD
Delavirdine—CYP2C9—Metabolism—ENO2—hematologic cancer	3.3e-06	0.000193	CbGpPWpGaD
Delavirdine—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CD—hematologic cancer	3.28e-06	0.000192	CbGpPWpGaD
Delavirdine—CYP2C8—Metabolism—CD44—hematologic cancer	3.27e-06	0.000191	CbGpPWpGaD
Delavirdine—CYP2C8—Metabolism—NQO1—hematologic cancer	3.27e-06	0.000191	CbGpPWpGaD
Delavirdine—CYP2C19—Metabolism of lipids and lipoproteins—ALB—hematologic cancer	3.24e-06	0.000189	CbGpPWpGaD
Delavirdine—CYP2D6—Metabolism—GSTT1—hematologic cancer	3.23e-06	0.000189	CbGpPWpGaD
Delavirdine—CYP1A2—Metabolism—SLC22A1—hematologic cancer	3.23e-06	0.000189	CbGpPWpGaD
Delavirdine—CYP1A2—Metabolism—CRABP1—hematologic cancer	3.23e-06	0.000189	CbGpPWpGaD
Delavirdine—CYP3A4—Metabolism—IDH2—hematologic cancer	3.2e-06	0.000187	CbGpPWpGaD
Delavirdine—CYP3A4—Metabolism—HMMR—hematologic cancer	3.2e-06	0.000187	CbGpPWpGaD
Delavirdine—CYP2C9—Metabolism—GSTT1—hematologic cancer	3.2e-06	0.000187	CbGpPWpGaD
Delavirdine—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CB—hematologic cancer	3.2e-06	0.000187	CbGpPWpGaD
Delavirdine—CYP2D6—Metabolism—SDC1—hematologic cancer	3.16e-06	0.000185	CbGpPWpGaD
Delavirdine—CYP2C9—Metabolism of lipids and lipoproteins—CREBBP—hematologic cancer	3.15e-06	0.000184	CbGpPWpGaD
Delavirdine—CYP3A5—Metabolism—GSTP1—hematologic cancer	3.15e-06	0.000184	CbGpPWpGaD
Delavirdine—CYP1A2—Metabolism—ALOX5—hematologic cancer	3.14e-06	0.000184	CbGpPWpGaD
Delavirdine—CYP2C9—Metabolism—SDC1—hematologic cancer	3.13e-06	0.000183	CbGpPWpGaD
Delavirdine—CYP2C19—Metabolism of lipids and lipoproteins—PIK3R1—hematologic cancer	3.09e-06	0.000181	CbGpPWpGaD
Delavirdine—CYP2C8—Metabolism—CYCS—hematologic cancer	3.09e-06	0.000181	CbGpPWpGaD
Delavirdine—CYP2C8—Metabolism—HSP90AA1—hematologic cancer	3.07e-06	0.00018	CbGpPWpGaD
Delavirdine—CYP1A2—Metabolism—NUP98—hematologic cancer	3.04e-06	0.000178	CbGpPWpGaD
Delavirdine—CYP3A4—Metabolism—ARNTL—hematologic cancer	3.01e-06	0.000176	CbGpPWpGaD
Delavirdine—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CD—hematologic cancer	2.99e-06	0.000175	CbGpPWpGaD
Delavirdine—CYP3A5—Metabolism—ABCB1—hematologic cancer	2.98e-06	0.000174	CbGpPWpGaD
Delavirdine—CYP3A7—Metabolism—PIK3CG—hematologic cancer	2.97e-06	0.000174	CbGpPWpGaD
Delavirdine—CYP1A2—Metabolism—ADCY7—hematologic cancer	2.96e-06	0.000173	CbGpPWpGaD
Delavirdine—CYP1A2—Metabolism—NCOA3—hematologic cancer	2.96e-06	0.000173	CbGpPWpGaD
Delavirdine—CYP2C9—Metabolism of lipids and lipoproteins—ALB—hematologic cancer	2.95e-06	0.000173	CbGpPWpGaD
Delavirdine—CYP1A2—Metabolism—NUP214—hematologic cancer	2.94e-06	0.000172	CbGpPWpGaD
Delavirdine—CYP3A4—Metabolism—CA9—hematologic cancer	2.93e-06	0.000171	CbGpPWpGaD
Delavirdine—CYP3A4—Metabolism—ACP5—hematologic cancer	2.93e-06	0.000171	CbGpPWpGaD
Delavirdine—CYP2C19—Metabolism—CD44—hematologic cancer	2.92e-06	0.000171	CbGpPWpGaD
Delavirdine—CYP2C19—Metabolism—NQO1—hematologic cancer	2.92e-06	0.000171	CbGpPWpGaD
Delavirdine—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CG—hematologic cancer	2.9e-06	0.00017	CbGpPWpGaD
Delavirdine—CYP3A5—Metabolism—GSTM1—hematologic cancer	2.89e-06	0.000169	CbGpPWpGaD
Delavirdine—CYP3A5—Metabolism—NCOR1—hematologic cancer	2.89e-06	0.000169	CbGpPWpGaD
Delavirdine—CYP3A4—Metabolism—NCOR2—hematologic cancer	2.89e-06	0.000169	CbGpPWpGaD
Delavirdine—CYP1A2—Metabolism—MTR—hematologic cancer	2.88e-06	0.000168	CbGpPWpGaD
Delavirdine—CYP1A2—Metabolism—ABCG2—hematologic cancer	2.88e-06	0.000168	CbGpPWpGaD
Delavirdine—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CB—hematologic cancer	2.86e-06	0.000167	CbGpPWpGaD
Delavirdine—CYP2C9—Metabolism of lipids and lipoproteins—PIK3R1—hematologic cancer	2.82e-06	0.000165	CbGpPWpGaD
Delavirdine—CYP1A2—Metabolism—ENO2—hematologic cancer	2.82e-06	0.000165	CbGpPWpGaD
Delavirdine—CYP2C8—Metabolism of lipids and lipoproteins—PTEN—hematologic cancer	2.77e-06	0.000162	CbGpPWpGaD
Delavirdine—CYP2C19—Metabolism—CYCS—hematologic cancer	2.76e-06	0.000162	CbGpPWpGaD
Delavirdine—CYP3A7—Metabolism—CREBBP—hematologic cancer	2.75e-06	0.000161	CbGpPWpGaD
Delavirdine—CYP3A4—Metabolism—IDH1—hematologic cancer	2.75e-06	0.000161	CbGpPWpGaD
Delavirdine—CYP2C19—Metabolism—HSP90AA1—hematologic cancer	2.74e-06	0.00016	CbGpPWpGaD
Delavirdine—CYP1A2—Metabolism—GSTT1—hematologic cancer	2.74e-06	0.00016	CbGpPWpGaD
Delavirdine—CYP2C8—Metabolism—GSTP1—hematologic cancer	2.73e-06	0.00016	CbGpPWpGaD
Delavirdine—CYP3A4—Metabolism—TXN—hematologic cancer	2.72e-06	0.000159	CbGpPWpGaD
Delavirdine—CYP3A4—Metabolism—ABCC3—hematologic cancer	2.72e-06	0.000159	CbGpPWpGaD
Delavirdine—CYP3A4—Metabolism—GSTO1—hematologic cancer	2.72e-06	0.000159	CbGpPWpGaD
Delavirdine—CYP1A2—Metabolism of lipids and lipoproteins—CREBBP—hematologic cancer	2.69e-06	0.000158	CbGpPWpGaD
Delavirdine—CYP2D6—Metabolism—CD44—hematologic cancer	2.68e-06	0.000157	CbGpPWpGaD
Delavirdine—CYP2D6—Metabolism—NQO1—hematologic cancer	2.68e-06	0.000157	CbGpPWpGaD
Delavirdine—CYP1A2—Metabolism—SDC1—hematologic cancer	2.67e-06	0.000156	CbGpPWpGaD
Delavirdine—CYP3A4—Metabolism—SPHK1—hematologic cancer	2.66e-06	0.000156	CbGpPWpGaD
Delavirdine—CYP2C9—Metabolism—CD44—hematologic cancer	2.66e-06	0.000156	CbGpPWpGaD
Delavirdine—CYP2C9—Metabolism—NQO1—hematologic cancer	2.66e-06	0.000156	CbGpPWpGaD
Delavirdine—CYP2C8—Metabolism of lipids and lipoproteins—EP300—hematologic cancer	2.64e-06	0.000154	CbGpPWpGaD
Delavirdine—CYP3A7—Metabolism—PIK3CD—hematologic cancer	2.61e-06	0.000153	CbGpPWpGaD
Delavirdine—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CB—hematologic cancer	2.6e-06	0.000152	CbGpPWpGaD
Delavirdine—CYP2C8—Metabolism—ABCB1—hematologic cancer	2.58e-06	0.000151	CbGpPWpGaD
Delavirdine—CYP3A7—Metabolism—ALB—hematologic cancer	2.58e-06	0.000151	CbGpPWpGaD
Delavirdine—CYP3A4—Metabolism—UGT1A1—hematologic cancer	2.56e-06	0.00015	CbGpPWpGaD
Delavirdine—CYP3A5—Metabolism—MTHFR—hematologic cancer	2.56e-06	0.00015	CbGpPWpGaD
Delavirdine—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CD—hematologic cancer	2.55e-06	0.000149	CbGpPWpGaD
Delavirdine—CYP2D6—Metabolism—CYCS—hematologic cancer	2.54e-06	0.000149	CbGpPWpGaD
Delavirdine—CYP2D6—Metabolism—HSP90AA1—hematologic cancer	2.52e-06	0.000148	CbGpPWpGaD
Delavirdine—CYP1A2—Metabolism of lipids and lipoproteins—ALB—hematologic cancer	2.52e-06	0.000148	CbGpPWpGaD
Delavirdine—CYP2C9—Metabolism—CYCS—hematologic cancer	2.52e-06	0.000147	CbGpPWpGaD
Delavirdine—CYP2C8—Metabolism—NCOR1—hematologic cancer	2.5e-06	0.000147	CbGpPWpGaD
Delavirdine—CYP2C8—Metabolism—GSTM1—hematologic cancer	2.5e-06	0.000147	CbGpPWpGaD
Delavirdine—CYP2C9—Metabolism—HSP90AA1—hematologic cancer	2.5e-06	0.000146	CbGpPWpGaD
Delavirdine—CYP3A4—Metabolism—SLC22A1—hematologic cancer	2.49e-06	0.000146	CbGpPWpGaD
Delavirdine—CYP3A4—Metabolism—CRABP1—hematologic cancer	2.49e-06	0.000146	CbGpPWpGaD
Delavirdine—CYP2C19—Metabolism of lipids and lipoproteins—PTEN—hematologic cancer	2.47e-06	0.000144	CbGpPWpGaD
Delavirdine—CYP3A7—Metabolism—PIK3R1—hematologic cancer	2.47e-06	0.000144	CbGpPWpGaD
Delavirdine—CYP2C19—Metabolism—GSTP1—hematologic cancer	2.43e-06	0.000142	CbGpPWpGaD
Delavirdine—CYP3A4—Metabolism—ALOX5—hematologic cancer	2.43e-06	0.000142	CbGpPWpGaD
Delavirdine—CYP1A2—Metabolism of lipids and lipoproteins—PIK3R1—hematologic cancer	2.41e-06	0.000141	CbGpPWpGaD
Delavirdine—CYP2C19—Metabolism of lipids and lipoproteins—EP300—hematologic cancer	2.35e-06	0.000138	CbGpPWpGaD
Delavirdine—CYP3A4—Metabolism—NUP98—hematologic cancer	2.35e-06	0.000138	CbGpPWpGaD
Delavirdine—CYP2C19—Metabolism—ABCB1—hematologic cancer	2.3e-06	0.000135	CbGpPWpGaD
Delavirdine—CYP3A4—Metabolism—ADCY7—hematologic cancer	2.28e-06	0.000133	CbGpPWpGaD
Delavirdine—CYP3A4—Metabolism—NCOA3—hematologic cancer	2.28e-06	0.000133	CbGpPWpGaD
Delavirdine—CYP3A7—Metabolism—PIK3CB—hematologic cancer	2.28e-06	0.000133	CbGpPWpGaD
Delavirdine—CYP1A2—Metabolism—CD44—hematologic cancer	2.27e-06	0.000133	CbGpPWpGaD
Delavirdine—CYP1A2—Metabolism—NQO1—hematologic cancer	2.27e-06	0.000133	CbGpPWpGaD
Delavirdine—CYP3A4—Metabolism—NUP214—hematologic cancer	2.27e-06	0.000133	CbGpPWpGaD
Delavirdine—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—hematologic cancer	2.25e-06	0.000132	CbGpPWpGaD
Delavirdine—CYP2D6—Metabolism—GSTP1—hematologic cancer	2.24e-06	0.000131	CbGpPWpGaD
Delavirdine—CYP2C19—Metabolism—GSTM1—hematologic cancer	2.24e-06	0.000131	CbGpPWpGaD
Delavirdine—CYP2C19—Metabolism—NCOR1—hematologic cancer	2.24e-06	0.000131	CbGpPWpGaD
Delavirdine—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CB—hematologic cancer	2.23e-06	0.00013	CbGpPWpGaD
Delavirdine—CYP3A4—Metabolism—MTR—hematologic cancer	2.22e-06	0.00013	CbGpPWpGaD
Delavirdine—CYP3A4—Metabolism—ABCG2—hematologic cancer	2.22e-06	0.00013	CbGpPWpGaD
Delavirdine—CYP2C9—Metabolism—GSTP1—hematologic cancer	2.22e-06	0.00013	CbGpPWpGaD
Delavirdine—CYP2C8—Metabolism—MTHFR—hematologic cancer	2.21e-06	0.00013	CbGpPWpGaD
Delavirdine—CYP3A4—Metabolism—ENO2—hematologic cancer	2.18e-06	0.000127	CbGpPWpGaD
Delavirdine—CYP1A2—Metabolism—CYCS—hematologic cancer	2.15e-06	0.000126	CbGpPWpGaD
Delavirdine—CYP3A5—Metabolism—PIK3CG—hematologic cancer	2.15e-06	0.000126	CbGpPWpGaD
Delavirdine—CYP2C9—Metabolism of lipids and lipoproteins—EP300—hematologic cancer	2.15e-06	0.000126	CbGpPWpGaD
Delavirdine—CYP1A2—Metabolism—HSP90AA1—hematologic cancer	2.14e-06	0.000125	CbGpPWpGaD
Delavirdine—CYP2D6—Metabolism—ABCB1—hematologic cancer	2.12e-06	0.000124	CbGpPWpGaD
Delavirdine—CYP3A4—Metabolism—GSTT1—hematologic cancer	2.11e-06	0.000124	CbGpPWpGaD
Delavirdine—CYP2C9—Metabolism—ABCB1—hematologic cancer	2.1e-06	0.000123	CbGpPWpGaD
Delavirdine—CYP3A4—Metabolism—SDC1—hematologic cancer	2.06e-06	0.000121	CbGpPWpGaD
Delavirdine—CYP2D6—Metabolism—GSTM1—hematologic cancer	2.06e-06	0.00012	CbGpPWpGaD
Delavirdine—CYP2D6—Metabolism—NCOR1—hematologic cancer	2.06e-06	0.00012	CbGpPWpGaD
Delavirdine—CYP2C9—Metabolism—GSTM1—hematologic cancer	2.04e-06	0.000119	CbGpPWpGaD
Delavirdine—CYP2C9—Metabolism—NCOR1—hematologic cancer	2.04e-06	0.000119	CbGpPWpGaD
Delavirdine—CYP3A5—Metabolism—CREBBP—hematologic cancer	1.99e-06	0.000117	CbGpPWpGaD
Delavirdine—CYP2C19—Metabolism—MTHFR—hematologic cancer	1.98e-06	0.000116	CbGpPWpGaD
Delavirdine—CYP3A7—Metabolism—PTEN—hematologic cancer	1.97e-06	0.000115	CbGpPWpGaD
Delavirdine—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CA—hematologic cancer	1.95e-06	0.000114	CbGpPWpGaD
Delavirdine—CYP1A2—Metabolism of lipids and lipoproteins—PTEN—hematologic cancer	1.92e-06	0.000113	CbGpPWpGaD
Delavirdine—CYP1A2—Metabolism—GSTP1—hematologic cancer	1.9e-06	0.000111	CbGpPWpGaD
Delavirdine—CYP3A5—Metabolism—PIK3CD—hematologic cancer	1.89e-06	0.00011	CbGpPWpGaD
Delavirdine—CYP3A7—Metabolism—EP300—hematologic cancer	1.88e-06	0.00011	CbGpPWpGaD
Delavirdine—CYP3A5—Metabolism—ALB—hematologic cancer	1.86e-06	0.000109	CbGpPWpGaD
Delavirdine—CYP2C8—Metabolism—PIK3CG—hematologic cancer	1.86e-06	0.000109	CbGpPWpGaD
Delavirdine—CYP1A2—Metabolism of lipids and lipoproteins—EP300—hematologic cancer	1.83e-06	0.000107	CbGpPWpGaD
Delavirdine—CYP2D6—Metabolism—MTHFR—hematologic cancer	1.82e-06	0.000106	CbGpPWpGaD
Delavirdine—CYP2C9—Metabolism—MTHFR—hematologic cancer	1.8e-06	0.000105	CbGpPWpGaD
Delavirdine—CYP1A2—Metabolism—ABCB1—hematologic cancer	1.79e-06	0.000105	CbGpPWpGaD
Delavirdine—CYP3A5—Metabolism—PIK3R1—hematologic cancer	1.78e-06	0.000104	CbGpPWpGaD
Delavirdine—CYP3A4—Metabolism—NQO1—hematologic cancer	1.75e-06	0.000103	CbGpPWpGaD
Delavirdine—CYP3A4—Metabolism—CD44—hematologic cancer	1.75e-06	0.000103	CbGpPWpGaD
Delavirdine—CYP1A2—Metabolism—GSTM1—hematologic cancer	1.74e-06	0.000102	CbGpPWpGaD
Delavirdine—CYP1A2—Metabolism—NCOR1—hematologic cancer	1.74e-06	0.000102	CbGpPWpGaD
Delavirdine—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—hematologic cancer	1.74e-06	0.000102	CbGpPWpGaD
Delavirdine—CYP2C8—Metabolism—CREBBP—hematologic cancer	1.72e-06	0.000101	CbGpPWpGaD
Delavirdine—CYP2C19—Metabolism—PIK3CG—hematologic cancer	1.66e-06	9.71e-05	CbGpPWpGaD
Delavirdine—CYP3A4—Metabolism—CYCS—hematologic cancer	1.66e-06	9.71e-05	CbGpPWpGaD
Delavirdine—CYP3A4—Metabolism—HSP90AA1—hematologic cancer	1.65e-06	9.65e-05	CbGpPWpGaD
Delavirdine—CYP3A5—Metabolism—PIK3CB—hematologic cancer	1.65e-06	9.63e-05	CbGpPWpGaD
Delavirdine—CYP2C8—Metabolism—PIK3CD—hematologic cancer	1.64e-06	9.57e-05	CbGpPWpGaD
Delavirdine—CYP2C8—Metabolism—ALB—hematologic cancer	1.61e-06	9.45e-05	CbGpPWpGaD
Delavirdine—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—hematologic cancer	1.59e-06	9.29e-05	CbGpPWpGaD
Delavirdine—CYP2C8—Metabolism—PIK3R1—hematologic cancer	1.54e-06	9.04e-05	CbGpPWpGaD
Delavirdine—CYP1A2—Metabolism—MTHFR—hematologic cancer	1.54e-06	9.01e-05	CbGpPWpGaD
Delavirdine—CYP2C19—Metabolism—CREBBP—hematologic cancer	1.54e-06	9.01e-05	CbGpPWpGaD
Delavirdine—CYP2D6—Metabolism—PIK3CG—hematologic cancer	1.53e-06	8.94e-05	CbGpPWpGaD
Delavirdine—CYP2C9—Metabolism—PIK3CG—hematologic cancer	1.51e-06	8.86e-05	CbGpPWpGaD
Delavirdine—CYP3A4—Metabolism—GSTP1—hematologic cancer	1.46e-06	8.56e-05	CbGpPWpGaD
Delavirdine—CYP2C19—Metabolism—PIK3CD—hematologic cancer	1.46e-06	8.54e-05	CbGpPWpGaD
Delavirdine—CYP2C19—Metabolism—ALB—hematologic cancer	1.44e-06	8.43e-05	CbGpPWpGaD
Delavirdine—CYP2C8—Metabolism—PIK3CB—hematologic cancer	1.43e-06	8.34e-05	CbGpPWpGaD
Delavirdine—CYP3A5—Metabolism—PTEN—hematologic cancer	1.42e-06	8.32e-05	CbGpPWpGaD
Delavirdine—CYP2D6—Metabolism—CREBBP—hematologic cancer	1.42e-06	8.28e-05	CbGpPWpGaD
Delavirdine—CYP2C9—Metabolism—CREBBP—hematologic cancer	1.4e-06	8.21e-05	CbGpPWpGaD
Delavirdine—CYP3A7—Metabolism—PIK3CA—hematologic cancer	1.39e-06	8.12e-05	CbGpPWpGaD
Delavirdine—CYP3A4—Metabolism—ABCB1—hematologic cancer	1.38e-06	8.1e-05	CbGpPWpGaD
Delavirdine—CYP2C19—Metabolism—PIK3R1—hematologic cancer	1.38e-06	8.06e-05	CbGpPWpGaD
Delavirdine—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—hematologic cancer	1.36e-06	7.94e-05	CbGpPWpGaD
Delavirdine—CYP3A5—Metabolism—EP300—hematologic cancer	1.36e-06	7.93e-05	CbGpPWpGaD
Delavirdine—CYP3A4—Metabolism—GSTM1—hematologic cancer	1.34e-06	7.87e-05	CbGpPWpGaD
Delavirdine—CYP3A4—Metabolism—NCOR1—hematologic cancer	1.34e-06	7.87e-05	CbGpPWpGaD
Delavirdine—CYP2D6—Metabolism—PIK3CD—hematologic cancer	1.34e-06	7.86e-05	CbGpPWpGaD
Delavirdine—CYP2C9—Metabolism—PIK3CD—hematologic cancer	1.33e-06	7.79e-05	CbGpPWpGaD
Delavirdine—CYP2D6—Metabolism—ALB—hematologic cancer	1.33e-06	7.75e-05	CbGpPWpGaD
Delavirdine—CYP2C9—Metabolism—ALB—hematologic cancer	1.31e-06	7.69e-05	CbGpPWpGaD
Delavirdine—CYP1A2—Metabolism—PIK3CG—hematologic cancer	1.29e-06	7.57e-05	CbGpPWpGaD
Delavirdine—CYP2C19—Metabolism—PIK3CB—hematologic cancer	1.27e-06	7.44e-05	CbGpPWpGaD
Delavirdine—CYP2D6—Metabolism—PIK3R1—hematologic cancer	1.27e-06	7.42e-05	CbGpPWpGaD
Delavirdine—CYP2C9—Metabolism—PIK3R1—hematologic cancer	1.26e-06	7.35e-05	CbGpPWpGaD
Delavirdine—CYP2C8—Metabolism—PTEN—hematologic cancer	1.23e-06	7.21e-05	CbGpPWpGaD
Delavirdine—CYP1A2—Metabolism—CREBBP—hematologic cancer	1.2e-06	7.02e-05	CbGpPWpGaD
Delavirdine—CYP3A4—Metabolism—MTHFR—hematologic cancer	1.19e-06	6.95e-05	CbGpPWpGaD
Delavirdine—CYP2C8—Metabolism—EP300—hematologic cancer	1.17e-06	6.87e-05	CbGpPWpGaD
Delavirdine—CYP2D6—Metabolism—PIK3CB—hematologic cancer	1.17e-06	6.85e-05	CbGpPWpGaD
Delavirdine—CYP2C9—Metabolism—PIK3CB—hematologic cancer	1.16e-06	6.79e-05	CbGpPWpGaD
Delavirdine—CYP1A2—Metabolism—PIK3CD—hematologic cancer	1.14e-06	6.65e-05	CbGpPWpGaD
Delavirdine—CYP3A7—Metabolism—AKT1—hematologic cancer	1.13e-06	6.63e-05	CbGpPWpGaD
Delavirdine—CYP1A2—Metabolism—ALB—hematologic cancer	1.12e-06	6.57e-05	CbGpPWpGaD
Delavirdine—CYP2C19—Metabolism—PTEN—hematologic cancer	1.1e-06	6.43e-05	CbGpPWpGaD
Delavirdine—CYP1A2—Metabolism—PIK3R1—hematologic cancer	1.07e-06	6.28e-05	CbGpPWpGaD
Delavirdine—CYP2C19—Metabolism—EP300—hematologic cancer	1.05e-06	6.13e-05	CbGpPWpGaD
Delavirdine—CYP2D6—Metabolism—PTEN—hematologic cancer	1.01e-06	5.92e-05	CbGpPWpGaD
Delavirdine—CYP3A5—Metabolism—PIK3CA—hematologic cancer	1e-06	5.87e-05	CbGpPWpGaD
Delavirdine—CYP2C9—Metabolism—PTEN—hematologic cancer	1e-06	5.87e-05	CbGpPWpGaD
Delavirdine—CYP3A4—Metabolism—PIK3CG—hematologic cancer	9.98e-07	5.84e-05	CbGpPWpGaD
Delavirdine—CYP1A2—Metabolism—PIK3CB—hematologic cancer	9.91e-07	5.8e-05	CbGpPWpGaD
Delavirdine—CYP2D6—Metabolism—EP300—hematologic cancer	9.64e-07	5.64e-05	CbGpPWpGaD
Delavirdine—CYP2C9—Metabolism—EP300—hematologic cancer	9.56e-07	5.59e-05	CbGpPWpGaD
Delavirdine—CYP3A4—Metabolism—CREBBP—hematologic cancer	9.26e-07	5.42e-05	CbGpPWpGaD
Delavirdine—CYP3A4—Metabolism—PIK3CD—hematologic cancer	8.78e-07	5.14e-05	CbGpPWpGaD
Delavirdine—CYP2C8—Metabolism—PIK3CA—hematologic cancer	8.69e-07	5.08e-05	CbGpPWpGaD
Delavirdine—CYP3A4—Metabolism—ALB—hematologic cancer	8.66e-07	5.07e-05	CbGpPWpGaD
Delavirdine—CYP1A2—Metabolism—PTEN—hematologic cancer	8.57e-07	5.01e-05	CbGpPWpGaD
Delavirdine—CYP3A4—Metabolism—PIK3R1—hematologic cancer	8.29e-07	4.85e-05	CbGpPWpGaD
Delavirdine—CYP3A5—Metabolism—AKT1—hematologic cancer	8.19e-07	4.8e-05	CbGpPWpGaD
Delavirdine—CYP1A2—Metabolism—EP300—hematologic cancer	8.17e-07	4.78e-05	CbGpPWpGaD
Delavirdine—CYP2C19—Metabolism—PIK3CA—hematologic cancer	7.75e-07	4.54e-05	CbGpPWpGaD
Delavirdine—CYP3A4—Metabolism—PIK3CB—hematologic cancer	7.65e-07	4.48e-05	CbGpPWpGaD
Delavirdine—CYP2D6—Metabolism—PIK3CA—hematologic cancer	7.13e-07	4.17e-05	CbGpPWpGaD
Delavirdine—CYP2C8—Metabolism—AKT1—hematologic cancer	7.1e-07	4.15e-05	CbGpPWpGaD
Delavirdine—CYP2C9—Metabolism—PIK3CA—hematologic cancer	7.07e-07	4.14e-05	CbGpPWpGaD
Delavirdine—CYP3A4—Metabolism—PTEN—hematologic cancer	6.61e-07	3.87e-05	CbGpPWpGaD
Delavirdine—CYP2C19—Metabolism—AKT1—hematologic cancer	6.34e-07	3.71e-05	CbGpPWpGaD
Delavirdine—CYP3A4—Metabolism—EP300—hematologic cancer	6.3e-07	3.69e-05	CbGpPWpGaD
Delavirdine—CYP1A2—Metabolism—PIK3CA—hematologic cancer	6.04e-07	3.54e-05	CbGpPWpGaD
Delavirdine—CYP2D6—Metabolism—AKT1—hematologic cancer	5.83e-07	3.41e-05	CbGpPWpGaD
Delavirdine—CYP2C9—Metabolism—AKT1—hematologic cancer	5.78e-07	3.38e-05	CbGpPWpGaD
Delavirdine—CYP1A2—Metabolism—AKT1—hematologic cancer	4.94e-07	2.89e-05	CbGpPWpGaD
Delavirdine—CYP3A4—Metabolism—PIK3CA—hematologic cancer	4.66e-07	2.73e-05	CbGpPWpGaD
Delavirdine—CYP3A4—Metabolism—AKT1—hematologic cancer	3.81e-07	2.23e-05	CbGpPWpGaD
